This funding will support the development of high-resolution, comprehensive atlases of human brain morphology, advancing our understanding of neuroanatomy.

September 2021: Inga Koerte conducts research of brain trauma at LMU and Harvard Medical School. The physician and scientist is one of the winners of this year’s Prinzessin Therese von Bayern Preis.

August 2020: Dr. Suheyla Cetin Karayuma received the 2020 Brain and Behavior Research Foundation Young Investigator Grant for her grant proposal titled “Association of prenatal cannabis exposure and psychotic experiences in adolescents: a harmonized multi-site diffusion MRI study”. BBRF Young Investigator Grants enable promising investigators to either extend research fellowship training or begin careers as independent research faculty. The goal of the program is to help researchers launch careers in neuroscience and psychiatry and gather pilot data to apply for larger federal and university grants.

July 2019: In a recent article, Live Science reports on a study conducted by researchers at the University of Pennsylvania that found distinct brain changes in people who were potentially exposed to “sonic attacks” while working at the U.S. Embassy in Cuba. Dr. Martha Shenton gives her opinion on the neuroimaging techniques used in the study.

NIH: Dr. Westin received the R01 MH 074794 National Institutes of Health Award for his research project titled, “Novel DT-MRI Analyses of White Matter in Schizophrenia”. Dr. Shenton is the co-investigator.

NIMH: Dr. McCarley received the R01 MH 40799 National Institute of Mental Health grant for his research project titled, “Neurophysiological Studies of Schizophrenia”. Dr. Shenton is the co-investigator.

Dr. McCarley (principal investigator) and Dr. Shenton (co-principal investigator) were awarded the VA Schizophrenia Center grant for the research project titled, “Neuroimaging Insights into Schizophrenia & Treatment Implications”.

NIH: Drs. McCarley and Shenton were awarded the 1P50 MH 080272 NIH Mental Health Centers for Interventional Development and Applied Research (CIDAR) grant for the projects titled, “Vulnerability to Progression in Schizophrenia” (PI: Dr. McCarley) and “Vulnerability to White Matter Progression in Schizophrenia” (PI: Dr. Shenton).

Dr. Levitt (PI) and Dr. Shenton (investigator) received the VA Merit Award for the research project titled, “MR Brain Imaging of Frontal-Striatal- Thalamic Circuits in Schizophrenia”.

December 2007: Dr. Shenton was featured in The Scientist, in a special supplement on schizophrenia. Read article.

Winter 2007: Read article on the advances in schizophrenia research featured in Brigham and Women’s magazine.

1997-2007: For this decade in schizophrenia research, Dr. Shenton is listed as the 8th most cited schizophrenia researcher in the world, out of 26,117 authors. The database consists of 13,989 papers, 99 countries, 947 journals and 6,863 organizations. See an interview with Dr. Shenton.

Related articles in the past: For the period 1991-1999, Dr. Shenton was listed as the 14th most cited schizophrenia researcher, out of 24,088 authors. Moreover, her paper in the New England Journal of Medicine was the 4th most cited paper out of 19,506 papers. The database included 101 countries, 1, 139 journals and 5,514 organizations. See past interview with Dr. Shenton. Her review paper is also among the top 1% of breaking papers listed in ESI. She is also a co-author on the 10th most cited PTSD paper in the 1990′s in the area of PTSD research (for more details).

From the article: “On Friday, 30 March 2007, at the International Congress on Schizophrenia Research in Colorado Springs, Dr. Shenton of Harvard Medical School, Boston, chaired a symposium session entitled, “Evidence for endophenotypic markers in schizophrenia.” Young Investigator travel awardee Neeltje E. M. van Haren of the University Medical Centre Utrecht, the Netherlands, was there to report. In this session, the 10 speakers presented a number of findings that were relevant to possible endophenotypic markers in schizophrenia.”